Navigation Links
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Date:5/25/2011

PALO ALTO, Calif., May 25, 2011 /PRNewswire/ -- Vivo Ventures, LLC (“Vivo”) announced today the promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner in recognition of their contributions to the firm.

Dr. Yu first joined Vivo in 2004 and has been a Partner since 2007.   He currently serves as a Director of Sagent Pharmaceuticals, Nora Therapeutics and Synaptic International, and has been actively involved in many of the firm’s earlier private and public investments, including China KangHui Holdings, Achillion, Transcept, Tranzyme and Cubist.  In addition, he has had an operational role in a part-time capacity as Chief Business Officer of China KangHui Holdings overseeing their corporate development and investor relations efforts.  Prior to his time at Vivo, Dr. Yu was an early employee at aQuantive, which listed on Nasdaq in 2000 and ultimately was acquired for $6.5B by Microsoft.  Dr. Yu also currently serves on the Board of Governors for the Stanford Medical School Alumni Association.  Dr. Yu received his B.A. from Harvard University; his M.D. and MBA degrees are both from Stanford.

Dr. Zhao first began working with the firm in late 2005.  With his promotion to Managing Partner, he will now be heading Vivo’s China team.  He has made significant contributions to the firm’s success in China, including opening its Shanghai and Chengdu offices.  He was also instrumental in assisting in the formation of Vivo’s RMB denominated fund in partnership with the Chengdu Hi Tech Yinke Fund.  Dr. Zhao is actively involved in all of Vivo’s investments in China and will serve as the lead Vivo representative for Shanghai Hile, Sundise, and IMH.  Prior to joining Vivo, Dr. Zhao was a consultant with the Monitor Group focusing on life sciences.  Prior to that, he worked as a sales supervisor for Bristol Myers Squibb in Chengdu.  Dr. Zhao received his medical degree from West China University of Medical Sciences in Chengdu, his M.S. in Molecular Biology from Vrije University in Brussels, and his M.B.A. from Washington University, St. Louis.

"We are pleased to recognize the contributions of our new Managing Partners as we continue to strengthen and grow our team in the U.S. and in China,” said Frank Kung, Vivo Ventures co-founder and Senior Managing Partner.

About Vivo Ventures

Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $750M under management. With over 90 years of scientific and operational expertise in biotechnology, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, arrange licensing agreements and strategic alliances, recruit key management personnel, and acquire new products and technology to accelerate growth. Its current portfolio includes more than 60 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. For more information, please visit www.vivoventures.com.


'/>"/>
SOURCE Vivo Ventures, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
2. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
3. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
4. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
5. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
6. Leader Ventures Supports Innovative Drug Discovery Company Carmot
7. PharmaVentures Appoints Paul Phull as Senior Director
8. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
9. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
10. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
11. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology:
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... NuevaCare, a leading home care ... Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to its blog ... and read organized content on topics such as home care (generally) as well as ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American ... 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious list ... Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney General ...
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
Breaking Medicine News(10 mins):